在Lowe综合征中对OCRL的基编辑校正:在患者衍生纤维细胞中通过ABE介导的功能救援

相关实验视频

Updated: Jun 29, 2025

Efficient PAM-Less Base Editing for Zebrafish Modeling of Human Genetic Disease with zSpRY-ABE8e

Efficient PAM-Less Base Editing for Zebrafish Modeling of Human Genetic Disease with zSpRY-ABE8e

Published on: February 17, 2023

Siyu Chen¹, Chien-Hui Lo¹, Zhiquan Liu¹

¹Department of Ophthalmology, Stanford University School of Medicine, 1651 Page Mill Road, Rm 2220, Palo Alto, CA 94304, United States.

Human molecular genetics

|April 1, 2024

概括

使用腺基编辑器 (ABE) 的基因疗法对洛伊综合征,一种罕见的遗传疾病,显示出有前途. 这种新的方法纠正了OCRL基因的突变,恢复了蛋白质表达和细胞功能.

科学领域:

遗传学是一个遗传学.
分子生物学分子生物学
基因治疗基因治疗

背景情况:

洛伊综合征是一种罕见的X相关疾病,影响眼睛,脏和中枢神经系统.
它是由OCRL基因的突变引起的,该基因编码的是内醇多酸5-酸酶.
目前,对于洛伊综合征,还没有有效的向治疗方法.

研究的目的:

为了研究基编辑器 (ABE) 基因治疗洛伊综合征的潜力.
在患者衍生细胞中使用ABE技术纠正OCRL基因中的病原点突变.

主要方法:

利用ABE8e-NG系统纠正Lowe患者纤维细胞中的OCRL基因中的特定致病突变 (R844X).
在mRNA和蛋白质水平上评估了OCRL基因表达的恢复.
评估了与OCRL功能障碍相关的细胞异常的纠正,包括纤毛发育,微管定和细胞骨架组织.

主要成果:

在患者纤维细胞中,ABE介导的基因治疗成功地纠正了OCRL基因中的R844X突变.
在mRNA和蛋白质水平上恢复了OCRL表达.
扭转了OCRL功能障碍的细胞特征,例如纤毛发育和细胞骨组织的缺陷.

结论:

通过ABE介导的基因疗法是洛伊综合征的可行和有前途的治疗策略.
这项研究为应用ABE技术来治疗这种目前无法治愈的遗传疾病奠定了基础.

关键词:

细胞生物学细胞生物学纤维细胞的产生.基因编辑基因编辑基因治疗的基因疗法洛伊综合征 (Lowe Syndrome) 是一种疾病.

更多相关视频

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

CRISPR-Mediated Reorganization of Chromatin Loop Structure

CRISPR-Mediated Reorganization of Chromatin Loop Structure

Published on: September 14, 2018

相关概念视频

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Long-patch Base Excision Repair

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are: